Members Advisory Group LLC purchased a new position in shares of Tema Heart & Health ETF (NASDAQ:HRTS – Free Report) in the second quarter, Holdings Channel.com reports. The fund purchased 20,373 shares of the company’s stock, valued at approximately $398,000.
Several other institutional investors and hedge funds have also modified their holdings of HRTS. JPMorgan Chase & Co. acquired a new stake in Tema Heart & Health ETF in the second quarter valued at about $63,000. Jane Street Group LLC raised its stake in Tema Heart & Health ETF by 9.4% during the second quarter. Jane Street Group LLC now owns 37,164 shares of the company’s stock worth $1,062,000 after acquiring an additional 3,202 shares in the last quarter. Citadel Advisors LLC acquired a new position in Tema Heart & Health ETF during the third quarter worth about $243,000. Stifel Financial Corp lifted its holdings in shares of Tema Heart & Health ETF by 19.8% in the fourth quarter. Stifel Financial Corp now owns 33,647 shares of the company’s stock worth $1,187,000 after acquiring an additional 5,571 shares during the last quarter. Finally, Kestra Advisory Services LLC bought a new position in shares of Tema Heart & Health ETF in the fourth quarter worth about $27,000.
Tema Heart & Health ETF Trading Down 1.0%
HRTS opened at $37.57 on Friday. The company has a market cap of $55.98 million, a P/E ratio of 22.06 and a beta of 0.63. The company’s 50 day moving average is $37.13 and its 200-day moving average is $35.22. Tema Heart & Health ETF has a 1-year low of $29.54 and a 1-year high of $38.87.
About Tema Heart & Health ETF
The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.
Further Reading
- Five stocks we like better than Tema Heart & Health ETF
- Zscaler’s Strong Quarter Still Left Investors Waiting on 1 Key Signal
- Is Duolingo the Next Netflix-Style Comeback Story?
- GitLab’s AI Tools Are Starting to Turn Developer Demand Into Real Revenue
- GTA VI’s Console Problem Isn’t Take-Two’s Problem
Want to see what other hedge funds are holding HRTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tema Heart & Health ETF (NASDAQ:HRTS – Free Report).
Receive News & Ratings for Tema Heart & Health ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tema Heart & Health ETF and related companies with MarketBeat.com's FREE daily email newsletter.
